Geneexpression profile of THP-1 monocytesfollowing knockdown of DAP12, a causativegene for Nasu-Hakola disease.
Geneexpression profile of THP-1 monocytesfollowing knockdown of DAP12, a causativegene for Nasu-Hakola disease.
复制标题
DAP12(Nasu-Hakola 病的致病基因)敲低后 THP-1 单核细胞的基因表达谱。
DOI:
10.1007/s10571-011-9769-z
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Tabunoki H.
中科院分区:
文献类型:
--
作者:
Satoh J;Shimamura Y;Tabunoki H.
Nasu-Hakola disease (NHD), also designated polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, is a rare autosomal recessive disorder characterized by progressive presenile dementia and formation of multifocal bone cysts, caused by a loss-of-function mutation of DAP12 or TREM2. TREM2 and DAP12 constitute a receptor/adaptor complex expressed on osteoclasts, dendritic cells, macrophages, monocytes, and microglia. At present, the precise molecular mechanisms underlying development of leukoencephalopathy and bone cysts in NHD remain largely unknown. We established THP-1 human monocyte clones that stably express small interfering RNA targeting DAP12 for serving as a cellular model of NHD. Genome-wide transcriptome analysis identified a set of 22 genes consistently downregulated in DAP12 knockdown cells. They constituted the molecular network closely related to the network defined by cell-to-cell signaling and interaction, hematological system development and function, and inflammatory response, where NF-κB acts as a central regulator. These results suggest that a molecular defect of DAP12 in human monocytes deregulates the gene network pivotal for maintenance of myeloid cell function in NHD.